In a recent transaction, Anthony Mauro, President of Developed Markets at Viatris Inc (NASDAQ:VTRS), sold 250,000 shares of the company's common stock. The transaction, which took place on March 13, 2024, amounted to a total of $3,023,700, with the shares sold at a weighted average price of $12.0948 each. The sale was reported in a Form 4 filing with the Securities and Exchange Commission (SEC).
According to the details provided in the filing, the shares were sold in a range from $12.02 to $12.17. This price range represents the varied amounts at which the stock was disposed of during the transaction period. Mauro has committed to providing full information regarding the number of shares sold at each separate price within this range upon request.
After the sale, Anthony Mauro retained direct ownership of 243,044 shares of Viatris Inc. Additionally, the executive holds 5,574 shares indirectly through a 401(k) plan.
Viatris Inc, headquartered in Canonsburg, Pennsylvania, operates in the pharmaceutical preparations industry. The company, which is the product of a merger between Mylan N.V. and Upjohn, a division of Pfizer (NYSE:PFE), is known for providing access to medicines, sustainable operations, and community support.
Investors often monitor the trading activity of insiders for signals about a company's prospects and management's view of the stock's valuation. The sale by a high-ranking executive like Mauro may draw particular interest from the market.
InvestingPro Insights
Amidst the insider trading activity at Viatris Inc (NASDAQ:VTRS), investors may find the latest metrics and analyses from InvestingPro to be of particular value. The company's aggressive share buyback program is a notable InvestingPro Tip, indicating a management belief in the company's value. Additionally, Viatris has been recognized for its high shareholder yield, which could be appealing for investors seeking income alongside capital appreciation.
From a financial standpoint, Viatris has a market capitalization of $14.18 billion, and its current P/E ratio stands at a lofty 258.26. However, when adjusted for the last twelve months as of Q4 2023, the P/E ratio becomes more attractive at 10.09. This discrepancy may suggest that the market has had a short-term reaction to recent events, while the longer-term earnings potential remains robust. Furthermore, the company's strong return over the last three months, with a price total return of 16.22%, underscores its recent market performance.
For those considering an investment in Viatris, utilizing InvestingPro could provide an edge. There are additional InvestingPro Tips, including predictions of net income growth and profitability for the current year, which could be crucial for making informed decisions. To access these insights and more, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. With this resource, investors can stay ahead of market trends and gain a comprehensive understanding of Viatris’s financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.